Xanthine based inhibitors for therapeutics targeting phosphodiesterase 9A

dc.contributor.authorSingh, Nivedita
dc.date.accessioned2019-07-16T10:58:21Z
dc.date.accessioned2023-10-19T11:05:01Z
dc.date.available2019-07-16T10:58:21Z
dc.date.available2023-10-19T11:05:01Z
dc.date.issued2016
dc.descriptionSupervisors: Sanjukta Patra and Parameswar Krishnan Iyeren_US
dc.description.abstractXanthine is a versatile nitrogenous alkaloid. The pharmaceutical active nature of xanthine derivatives is widely known for treating various diseases. Therefore, xanthine can act as structurally rigid scaffold which provides enormous possibility for molecular diversity in drug development process. Xanthine based compounds are reported for their non-specific phosphodiesterase inhibition, however, xanthine based inhibitors have not been reported for PDE9A inhibition. With introduction of “xanthine” as a scaffold, the present study was an attempt to bring molecular diversification in PDE9A research. The current study was emphasized on two approaches – one was virtual screening to find out the possibilities of existing xanthine based derivatives to regulate the catalytic action of PDE9A and the second approach was to use the xanthine as scaffold for designing new xanthine derivatives and again the same xanthine was used as ‘starting material’ for synthesizing selected xanthine derivatives. Two schemes were developed based on getting clear understanding over the molecular structure of xanthine. The biological studies were carried out to understand the biological affinity of the selected virtual screened compounds and chemically synthesized new compounds by using spectrophotometric inhibition studies for structural activity relationship (SAR) analysis and thermal shift assay for stability studies of protein-ligand complex. The biological studies showed chemically synthesized xanthine derivatives as better inhibitors than virtual screened compounds.en_US
dc.identifier.otherROLL NO.11610615
dc.identifier.urihttps://gyan.iitg.ac.in/handle/123456789/1291
dc.language.isoenen_US
dc.relation.ispartofseriesTH-1894;
dc.subjectBIOSCIENCES AND BIOENGINEERINGen_US
dc.titleXanthine based inhibitors for therapeutics targeting phosphodiesterase 9Aen_US
dc.typeThesisen_US
Files
Original bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
Abstract-TH-1894_11610615.pdf
Size:
104.88 KB
Format:
Adobe Portable Document Format
Description:
Abstract
No Thumbnail Available
Name:
TH-1894_11610615.pdf
Size:
11.31 MB
Format:
Adobe Portable Document Format
Description:
Thesis
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: